Work

Abstract 5715: Enhancing PARP inhibitor efficacy with CDK12/7/9 degradation in prostate cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-5715

Authors: Fu Gui, Baishan Jiang, Jie Jiang, Marian Kalocsay, Anne Fassl, Steven P. Balk, Adam S. Kibel, Li Jia

Institutions: Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, Goethe University Frankfurt, University Hospital Frankfurt, Beth Israel Deaconess Medical Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409632098

Cites:

Cited by:

Related to: 10